Diagnostic Test: Validity Appraisal

  • Kameshwar Prasad


Validity is the extent to which the data are free from bias. The bias can occur in the selection of sample or measurement; therefore, you must ask whether:


Gold Standard Pleural Fluid Cardiac Enzyme Pretest Probability Gold Standard Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Further Reading

  1. Bates SE. Clinical applications of serum tumor markers. Ann Intern Med. 1991;115:623–38.PubMedCrossRefGoogle Scholar
  2. Begg CB, Greenes RA. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics. 1983;39:207–15.PubMedCrossRefGoogle Scholar
  3. Catalona WJ, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156–61.PubMedCrossRefGoogle Scholar
  4. Choi BC. Sensitivity and specificity of a single diagnostic test in the presence of work-up bias. J Clin Epidemiol. 1992;45:581–6.PubMedCrossRefGoogle Scholar
  5. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med. 1986;104:66–73.PubMedCrossRefGoogle Scholar
  6. Gray R, Begg CB, Greenes RA. Construction of receiver operating characteristic curves when disease verification is subject to selection bias. Med Decis Making. 1984;4:151–64.PubMedCrossRefGoogle Scholar
  7. Grinder PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic tests and procedure. Principles and applications. Ann Intern Med. 1981;94:557–600.Google Scholar
  8. Guyatt GH, Tugwell PX, Feeny DH, Haynes RB, Drummond M. A framework for clinical evaluation of diagnostic technologies. CMAJ. 1986;134:587–94.PubMedGoogle Scholar
  9. Guyatt G, Rennie D, editors. User’s guides to the medical literature: a manual for evidence-based clinical practice. Chicago: AMA Press; 2002. Scholar
  10. Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282:1061–6.PubMedCrossRefGoogle Scholar
  11. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978;299:926–30.PubMedCrossRefGoogle Scholar
  12. Sheps SB, Schechter MT. The assessment of diagnostic tests. A survey of current medical research. JAMA. 1984;104:60–6.Google Scholar
  13. Voss JD. Prostate cancer, screening, and prostate-specific antigen: promise or peril? J Gen Intern Med. 1994;9:468–74.PubMedCrossRefGoogle Scholar
  14. Wasson JH, Sox Jr HC, Neff RK, Goldman L. Clinical prediction rules, applications and methodological standards. N Engl J Med. 1985;313:793–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer India 2014

Authors and Affiliations

  • Kameshwar Prasad
    • 1
  1. 1.Department of Neurology Neurosciences Centre, and Clinical Epidemiology UnitAll India Institute of Medical SciencesNew Delhi DelhiIndia

Personalised recommendations